Drugs / Probiotics
Probiotics
Trials 14 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02771470 | Sep 2014 → Jul 2016 | chemotherapy-induced toxicity, lung cancer, nutritional disorder | Shandong University | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03840538 | Jan → Dec 2018 | Sjogren syndrome | Cairo University | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02035878 | Aug 2012 → Oct 2013 | anxiety, depressive disorder | Acadia University | Unknown | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT02113072 | Apr → Aug 2014 | asthma | Federal University of Pernambuco | Completed | No outcome recorded |
| Phase 3 | NCT01679366 | Oct 2012 → Sep 2013 | pharyngitis | Ziv Hospital | Completed | No outcome recorded |
| Phase 3 | NCT00161148 | Jan 2005 → May 2006 | primary sclerosing cholangitis | UMC Utrecht | Unknown | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT05603403 | Oct 2022 → Mar 2023 | digestive system disorder | Azidus Brasil | Completed | No outcome recorded |
| Phase 4 | NCT02519556 | Aug 2015 → Aug 2016 | atopic eczema | Casa Espirita Terra de Ismael | Completed | No outcome recorded |
| Phase not applicable6 trials | ||||||
| — | NCT07115342 | Aug → Oct 2025 overdue | allergic rhinitis | Tanta University | Recruiting | No outcome recorded |
| — | NCT03266315 | Dec 2022 → Jul 2024 | digestive system disorder | University of Calgary | Terminated | No outcome recorded |
| — | NCT04291469 | Mar → Dec 2022 | schizophrenia | First Affiliated Hospital Xi'an Jiaotong University | Unknown | No outcome recorded |
| — | NCT04693936 | Feb 2021 → Sep 2024 | Hashimoto thyroiditis, psoriasis | University of Crete | Unknown | No outcome recorded |
| — | NCT04383236 | Dec 2016 → Oct 2018 | aphthous stomatitis | Reham Lotfy Aggour | Completed | No outcome recorded |
| — | NCT00378300 | Jul 2007 → Jun 2008 | atopic eczema | University of California, Los Angeles | Withdrawn | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01839721 Comparator | Dec 2006 → Nov 2010 | cancer, diarrheal disease | CHU de Quebec-Universite Laval | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01501162 Comparator | Oct 2010 → Sep 2012 | alcoholic liver disease | Chuncheon Sacred Heart Hospital | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT03377322 Comparator | Dec 2017 → Jan 2019 | Parkinson disease | University of Malaya | Completed | No outcome recorded |
| — | NCT02350088 Comparator | Jan 2014 → Dec 2015 | — | Tongji Hospital | Unknown | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 18 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | probiotics | “The goal of this clinical trial is to learn if taking probiotics, vitamin D, or both together can help lower symptoms of allergic rhinitis (AR) and improve quality of life in adults.” NCT07115342 ↗13“Thirty-two Sjogren's syndrome patients were randomly allocated in two groups receiving either Probiotics or placebo capsules twice a day for 5 weeks.” PMID 32219478 ↗ Mar 2020 “The proposed project will investigate the effects of probiotics on anxiety and associated psychological and physiological factors in humans.” NCT02035878 ↗ “receive either multistrain probiotics capsules (n = 34) or identical-appearing placebo” PMID 33046607 ↗ Oct 2020 “Probiotics 40 billion 1 capsule per day” NCT04693936 ↗ “Other: Probiotics” NCT04383236 ↗ |
| Known as | Bifilact | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01839721 ↗ |
| Known as | FloraBaby | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03266315 ↗ |
| Known as | Organic Probiotics 7 Strains 20 Billion per gram | “The probiotic used in this study will be Organic Probiotics 7 Strains 20 Billion per gram purchased from Prescribed For Life.” NCT02035878 ↗ |
| Known as | Probiatop | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02519556 ↗ |
| Modality | Other / unclassified | “Probiotics (bacterial food supplements)” NCT00161148 ↗ |
| Route | Oral | “Oral Probiotics” NCT00378300 ↗ |